Table: begin end state 1 11 cytoplasmic 12 29 transmembrane 30 39 non-cytoplasmic 40 60 transmembrane 61 93 cytoplasmic 94 119 transmembrane 120 125 non-cytoplasmic 126 144 transmembrane 145 151 cytoplasmic 152 176 transmembrane 177 202 non-cytoplasmic 203 222 transmembrane 223 233 cytoplasmic 234 256 transmembrane 257 279 non-cytoplasmic 280 310 transmembrane 311 330 cytoplasmic 331 352 transmembrane 353 357 non-cytoplasmic 358 382 transmembrane 383 396 cytoplasmic 397 413 transmembrane 414 418 non-cytoplasmic 419 437 transmembrane 438 450 cytoplasmic 451 469 transmembrane 470 475 non-cytoplasmic
Input: >PfGW456L13_1875 MSEAPGKLKLGALVALVVGSMIGGGIFSLPQNMAASADVGAILIGWAITAVGMLTLAFVF QTLANRKPDLDGGVYAYAKAGFGDYMGFSSAWGYWISAWLGNVGYFVLLFSTLGYFFPIF GEGNTPAAVIGASVLLWAVHFLVLRGIKEAAFINLVTTVAKIVPLLLFMLIALFAFKLDI FTADIWGLKNPDLGSVMDQVRKMMLVTVWVFIGIEGASIFSARAEKRSDVGKATVIGFVT VLLFLVLVNVLSLGIMTQPELAKLQNPSMAAVLEHVVGHWGAVLISVGLIISLLGALLSW VLLCAEIMFAAAKDHTMPEFLRKENANHVPVNALWLTNAMVQVFLIITLFSASTYLSLIY LATSMILVPYLWSAAYALLLAVRGESYEGAAGERQKDLIIGAVALIYAVWLLYAGGIKYL LLSALLYAPGVILFAKAKLEINKPVFTNVEKLIFATVVVGAMVAAYGLYDGFLTL
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server